Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.

被引:0
|
作者
Kumar, D. [1 ]
Winstead, R. [1 ]
Iftikhar, H. [1 ]
Minniti, R. [1 ]
Khorsandi, S. [1 ]
Christensen, J. [1 ]
Yakubu, I. [1 ]
Moinuddin, I. [1 ]
Kamal, L. [1 ]
Halloran, P. [2 ]
Gupta, G. [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia Campus, Richmond, VA 23284 USA
[2] Univ Alberta, Edmonton, AB, Canada
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
119
引用
收藏
页码:385 / 386
页数:2
相关论文
共 50 条
  • [1] Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Raynaud, M.
    Halloran, P.
    Loupy, A.
    Chang, J.
    Reeve, J.
    Yakubu, I.
    Bobba, S.
    Kamal, L.
    Levy, M.
    Bhati, C.
    Kimball, P.
    King, A.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 453 - 453
  • [2] Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR)
    Moein, Mahmoudreza
    Gao, Shuqi X.
    Martin, Samuel J.
    Farkouh, Katie M.
    Li, Benson W.
    Ball, Angela S.
    Dvorai, Reut Hod
    Saidi, Reza F.
    [J]. TRANSPLANT IMMUNOLOGY, 2023, 76
  • [3] Impact of Belatacept Conversion on Renal Function, Histology, and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection
    Kumar, Dhiren
    Raynaud, Marc
    Chang, Jessica
    Reeve, Jeff
    Yakubu, Idris
    Kamal, Layla
    Levy, Marlon
    Bhati, Chandra
    Kimball, Pamela
    King, Anne
    Massey, Davis
    Halloran, Philip
    Gupta, Gaurav
    [J]. TRANSPLANTATION, 2021, 105 (03) : 660 - 667
  • [4] Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection
    Kumar, D.
    Yakubu, I.
    Paluri, S.
    Chachar, A.
    Chang, J.
    Moinuddin, I.
    Kamal, L.
    Levy, M.
    Bhati, C.
    King, A.
    Kimball, P.
    Halloran, P.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 405 - 405
  • [5] Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection.
    Zaffiri, L.
    Hallak, R.
    Leonard, S.
    Neely, M.
    Hulber, A.
    Berry, H.
    Young, K. A.
    Reynolds, J. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 992 - 993
  • [6] Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation
    Kumar, D.
    Gupta, G.
    Reeve, J.
    Sanghi, P.
    Bobba, S.
    Levy, M.
    Bhati, C.
    Kimball, P.
    Fattah, H.
    King, A.
    Massey, H.
    Halloran, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 310 - 310
  • [7] Conversion to Belatacept in kidney Transplant Recipients with Chronic Antibody Mediated Rejection (CAMR)
    Moein, Mahmoudreza
    Gao, Shuqi
    Martin, Samuel
    Farkouh, Katie
    Li, Benson
    Ball, Angela
    Dvorai, Reut Hod
    Saidi, Reza
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S36 - S36
  • [8] Lack of Response to Tocilizumab in Kidney Transplants with Chronic Antibody-Mediated Rejection.
    Kumar, D.
    Safavi, F.
    Sandhu, R.
    Halloran, P.
    Yakubu, I.
    Levy, M.
    Moinuddin, I.
    Kimball, P.
    Kamal, L.
    King, A.
    Massey, H.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 665 - 666
  • [9] Mesangiolysis in Chronic Active Antibody-mediated Rejection in Kidney Transplant Biopsies
    Suto, Yuki
    Oguchi, Hideyo
    Tochigi, Naobumi
    Mikami, Tetuo
    Shinoda, Kazunobu
    Honda, Kazuho
    Kounoue, Noriyuki
    Hashimoto, Junya
    Muramatsu, Masaki
    Itabashi, Yoshihiro
    Sakai, Ken
    [J]. NEPHRON, 2023, : 14 - 21
  • [10] Not all transplant glomerulopathy related to chronic antibody-mediated rejection.
    Akalin, Enver
    Barbachan e Silva, Mariel
    Mustofa, Sadia
    Bao, Yi
    Broin, Pilib O.
    [J]. TRANSPLANTATION, 2024, 108 (09) : 18 - 18